Career history of Brian Piper
Former positions of Brian Piper
Companies | Position | Start | End |
---|---|---|---|
PRELUDE THERAPEUTICS INCORPORATED | Director of Finance/CFO | 30/06/2019 | 18/11/2021 |
AEVI GENOMIC MEDICINE, INC. | Comptroller/Controller/Auditor | 08/02/2016 | 30/05/2019 |
Director of Finance/CFO | 08/02/2016 | 30/05/2019 | |
Investor Relations Contact | 31/03/2014 | 08/02/2016 | |
Corporate Secretary | 10/08/2017 | 30/05/2019 | |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | 31/12/2009 | 28/02/2014 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The private company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Corporate Officer/Principal | - | - |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Comptroller/Controller/Auditor | - | - |
Prexa Pharmaceuticals, Inc.
Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prexa Pharmaceuticals, Inc. developed oral small molecule monoamine reuptake inhibitors that act potently at the dopamine transporter. It engaged in developing small molecules designed to enhance the action of the neurotransmitter dopamine, potentially providing new alternatives to treating CNS diseases and disorders such as ADHD, depression, and Parkinson's disease. The company was founded in 2006 and was headquartered in Boston, MA. | Director/Board Member | 12/05/2011 | - |
Training of Brian Piper
University of Notre Dame | Undergraduate Degree |
Robert H. Smith School of Business | Masters Business Admin |
Statistics
International
United States | 9 |
Operational
Comptroller/Controller/Auditor | 2 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
Private companies | 5 |
---|---|
Prexa Pharmaceuticals, Inc.
Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prexa Pharmaceuticals, Inc. developed oral small molecule monoamine reuptake inhibitors that act potently at the dopamine transporter. It engaged in developing small molecules designed to enhance the action of the neurotransmitter dopamine, potentially providing new alternatives to treating CNS diseases and disorders such as ADHD, depression, and Parkinson's disease. The company was founded in 2006 and was headquartered in Boston, MA. | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The private company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
- Stock Market
- Insiders
- Brian Piper
- Experience